Поиск
Озвучивание недоступно Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

126. Song T., Jones D.M., Homsi Y. Therapeutic effect of anti-IL-5 on eosinophilic myocarditis with large pericardial effusion // BMJ Case Rep. 2017. Vol. 2017. pii: bcr-2016-218992.

127. Stoukas V., Dragovic L.J. Sudden deaths from eosinophilic coronary monoarteritis: a subset of spontaneous coronary artery dissection // Am. J. Forensic Med. Pathol. 2009. Vol. 30, N 3. P. 268-269.

128. Sugizaki Y., Tanaka H., Imanishi J. et al. Isolated primary cardiac sarcoidosis presenting as acute heart failure // Intern. Med. 2013. Vol. 52, N 1. P. 71-74.

129. Takaya Y., Kusano K., Nishii N. et al. Early and frequent defibrillator discharge in patients with cardiac sarcoidosis compared with patients with idiopathic dilated cardiomyopathy // Int. J. Cardiol. 2017. Vol. 240. P. 302-306.

130. Takeda N., Takahashi T., Seko Y. et al. Takayasu myocarditis mediated by cytotoxic T lymphocytes // Intern. Med. 2005. Vol. 44, N 3. P. 256-260.

131. Talwar K.K., Chopra P., Narula J. et al. Myocardial involvement and its response to immunosuppressive therapy in nonspecific aortoarteritis (Takayasu’s disease) - a study by endomyocardial biopsy // Int. J. Cardiol. 1988. Vol. 21. P. 323-334.

132. Terrier B., Karras A., Cluzel P. et al. Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis // Am. J. Cardiol. 2013. Vol. 111, N 2. P. 265-272.

133. Thomas G., Cohen Aubart F., Chiche L. et al. Lupus myocarditis: initial presentation and long-term outcomes in a multicentric series of 29 patients // J. Rheumatol. 2017. Vol. 44, N 1. P. 24-32.

134. Uijlings R., Balt J.C., Boom P., Wever E. Cardiac sarcoidosis mimicking non-ST-elevation myocardial infarction // J. Cardiovasc. Med. (Hagerstown). 2012. Vol. 13, N 4. P. 277-280.

135. Upadhyay G.A., Gainor J.F., Stamm L.M. et al. Acute nonrheumatic streptococcal myocarditis: STEMI mimic in young adults // Am. J. Med. 2012. Vol. 125, N 12. P. 1230-1233. pii: S0002-9343(12)00544-X.

136. Uusimaa P., Ylitalo K., Anttonen O. et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis // Europace. 2008. Vol. 10, N 6. P. 760-766.

137. Vasaiwala S.C., Finn C., Delpriore J. et al. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia // J. Cardiovasc. Electrophysiol. 2009. Vol. 20, N 5. P. 473-476.

138. Vasaturo S., Ploeg D.E., Buitrago G. et al. Right ventricular cardiomyopathy meeting the arrhythmogenic right ventricular dysplasia revised criteria? Don’t forget sarcoidosis! // Korean J. Radiol. 2015. Vol. 16, N 3. P. 668-672.

139. Vieira M.S., Antunes N., Carvalho H., Torres S. Renal cell carcinoma presenting as a stress cardiomyopathy // Eur. Heart J. Cardiovasc Imaging. 2013. Vol. 14, N 2. P. 192.

140. Wu S., Yang Y.M., Zhu J. et al. Clinical characteristics and outcomes of patients with myocarditis mimicking ST-segment elevation myocardial infarction: analysis of a case series // Medicine (Baltimore). 2017. Vol. 96, N 19. Article ID e6863.

141. Yano T., Ishimura S., Furukawa T. et al. Cardiac tamponade leading to the diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature // Heart Vessels. 2015. Vol. 30, N 6. P. 841-844.

142. Yufu K., Kondo H., Shinohara T. et al. Outcome of patients with cardiac sarcoidosis who received cardiac resynchronization therapy: comparison with dilated cardiomyopathy patients // J. Cardiovasc. Electrophysiol. 2017. Vol. 28, N 2. P. 177-181.

143. Zawadowski G., Klarich K., Moder K. et al. A contemporary case series of lupus myocarditis // Lupus. 2012. Vol. 21, N 13. P. 1378-1384.

Библиография (список литературы к главе 7)

1. Благова О.В., Недоступ А.В., Морозова Н.С. и др. Аритмогенная дисплазия правого желудочка: полиморфизм клинических проявлений // Кардиология. 2012. Т. 52, № 4. С. 85-94.

2. Благова О.В., Недоступ А.В., Седов В.П. и др. Некомпактный миокард как первичный феномен или следствие дисфункции миокарда: клинические маски синдрома // Кардиология. 2012. Т. 52, № 11. С. 17-26.

3. Митрофанова Л.Б., Моисеева О.М., Хащевская Д.А. и др. Некомпактный миокард левого желудочка. Клинико-морфологическое исследование // Арх. пат. 2016. Т. 78, № 2. С. 29-35.

4. Поляк М.Е., Мершина Е.А., Заклязьминская Е.В. Некомпактный миокард левого желудочка: симптом, синдром или вариант развития? // Рос. кардиол. журн. 2017. № 2. С. 106-113.

5. Руденская Г.Е., Тверская С.М., Чухрова А.Л. и др. Клинико-генеалогическое и молекулярно-генетическое исследование мышечной дистрофии Эмери-Дрейфуса // Журн. неврол. и психиатр. 2006. Т. 106, № 10. С. 58-85.

6. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Task Force Members // Eur. Heart J. 2013. Vol. 34, N 38. P. 2949-3003.

7. Accorsi F., Caruso G., Fiorilli R. et al. [Idiopathic dilatation of the atria: a syndrome? Description of a case of idiopathic biatrial dilatation, review of the literature and a proposal for a pathogenetic interpretation] // G. Ital. Cardiol. 1987. Vol. 17, N 10. P. 874-882.

8. Ackerman M.J., Priori S.G., Willems S. et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) // Europace. 2011. Vol. 13, N 8. P. 1077-1109.

9. Akdis D., Saguner A.M., Shah K. et al. Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome // Eur. Heart J. 2017. Vol. 38, N 19. P. 1498-1508.

10. Amzulescu M.S., Rousseau M.F., Ahn S.A. et al. Prognostic impact of hypertrabeculation and noncompaction phenotype in dilated cardiomyopathy: a CMR study // JACC Cardiovasc. Imaging. 2015. Vol. 8, N 8. P. 934-946.

11. Andreini D., Pontone G., Bogaert J. et al. Long-term prognostic value of cardiac magnetic resonance in left ventricle noncompaction: a prospective multicenter study // J. Am. Coll. Cardiol. 2016. Vol. 68, N 20. P. 2166-2181.

12. Andréoletti L., Lévêque N., Boulagnon C. et al. Viral causes of human myocarditis // Arch. Cardiovasc. Dis. 2009. Vol. 102, N 6-7. P. 559-568.

13. Angelini A., Thiene G., Boffa G.M. et al. Endomyocardial biopsy in right ventricular cardiomyopathy // Int. J. Cardiol. 1993. Vol. 40, N 3. P. 273-282.

14. Anguera Ferrando N., Pujadas Capmany R., Abardia Oliva X., Casasús Ramón A. [Familial association of arrhythmogenic dysplasia of the right ventricle and obstructive hypertrophic myocardiopathy] [Article in Spanish] // Med. Clin. (Barc.). 1993. Vol. 101, N 20. P. 798.

15. Anselme F., Moubarak G., Savouré A., Godin B. et al. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders // Heart Rhythm. 2013. Vol. 10, N 10. P. 1492-1498.

16. António M., Costa C., Venâncio M. et al. Left ventricular noncompaction: analysis of a pediatric population [Article in English, Portuguese] // Rev. Port. Cardiol. 2011. Vol. 30, N 3. P. 295-311.

17. Aras D., Ozeke O., Cay S. et al. Arrhythmogenic noncompaction cardiomyopathy: is there an echocardiographic phenotypic overlap of two distinct cardiomyopathies? // J. Cardiovasc. Ultrasound. 2015. Vol. 23, N 3. P. 186-190.

18. Arbustini E., Disertori M., Narula J. Primary prevention of sudden arrhythmic death in dilated cardiomyopathy: current guidelines and risk stratification // JACC Heart Fail. 2017. Vol. 5, N 1. P. 39-43.

19. Arbustini E., Favalli V., Narula N. et al. Left ventricular noncompaction: a distinct genetic cardiomyopathy? // J. Am. Coll. Cardiol. 2016. Vol. 68, N 9. P. 949-966.

20. Arimura S., Okada T., Tezuka T. et al. Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction // Science. 2014. Vol. 345, N 6203. P. 1505-1508.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Предыдущая страница

Следующая страница

Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава